R&D Locations: Cambridge, MA

In 2010, Cambridge was named one of Pfizer's worldwide research and development hubs, with approximately half of the current employees from the BioTherapeutics R&D organization located in several buildings along Cambridgepark Drive, Cambridge.

In February 2011, Pfizer announced plans to move two existing research units, Cardiovascular Medicine (CVMed) and Neuroscience from Groton, Conn. to Cambridge. In September 2011, Pfizer signed a lease with MIT for 180,000 square feet of lab and office space in Kendall Square, Cambridge, to house these two research units. The 610 Main St. building is scheduled to be completed in 2013. In 2011, CVMed moved into a temporary space at 620 Memorial Drive and in 2012, Neuroscience will move into a temporary space at 700 Main St., Cambridge.

In June 2011, Pfizer opened the Boston Centers for Therapeutic Innovation (CTI), an entrepreneurial network of partnerships with leading academic medical centers. These partnerships reduce the time and cost of drug discovery and development by accessing leading translational researchers. Boston is also the global headquarters for the CTI network, which has established partnerships in New York City and San Francisco.